Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Kwok Peng Ng"'
Autor:
Sudipta Biswas, Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt Schalper, Hua Zhang, Daniel J. Lindner, Anish Thomas, David MacPherson, Brian Gastman, David S. Schrump, Kwok-Kin Wong, Vamsidhar Velcheti, Yogen Saunthararajah
Publikováno v:
Cell Reports, Vol 42, Iss 8, Pp 113016- (2023)
Summary: Small cell lung cancers (SCLCs) rapidly resist cytotoxic chemotherapy and immune checkpoint inhibitor (ICI) treatments. New, non-cross-resistant therapies are thus needed. SCLC cells are committed into neuroendocrine lineage then maturation
Externí odkaz:
https://doaj.org/article/6e798291ce2a49cb8119368cddc4ce46
Autor:
Robert Molokie, Donald Lavelle, Michel Gowhari, Michael Pacini, Lani Krauz, Johara Hassan, Vinzon Ibanez, Maria A Ruiz, Kwok Peng Ng, Philip Woost, Tomas Radivoyevitch, Daisy Pacelli, Sherry Fada, Matthew Rump, Matthew Hsieh, John F Tisdale, James Jacobberger, Mitch Phelps, James Douglas Engel, Santhosh Saraf, Lewis L Hsu, Victor Gordeuk, Joseph DeSimone, Yogen Saunthararajah
Publikováno v:
PLoS Medicine, Vol 14, Iss 9, p e1002382 (2017)
BACKGROUND:Sickle cell disease (SCD), a congenital hemolytic anemia that exacts terrible global morbidity and mortality, is driven by polymerization of mutated sickle hemoglobin (HbS) in red blood cells (RBCs). Fetal hemoglobin (HbF) interferes with
Externí odkaz:
https://doaj.org/article/c7733c856c0b41248e7cccfad4c6af2d
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Supplementary Figure 3 from Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13750bf87ffc6c55770d68ded0c7fbbe
https://doi.org/10.1158/0008-5472.22390397
https://doi.org/10.1158/0008-5472.22390397
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Supplementary Figure 1 from Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d94ecf96c846f8f054f572df06f7c6
https://doi.org/10.1158/0008-5472.22390403
https://doi.org/10.1158/0008-5472.22390403
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Supplementary Figure Legends 1-3, Table Legend from Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167547f8a80b09bfbe46c8fd836cef4a
https://doi.org/10.1158/0008-5472.22390394
https://doi.org/10.1158/0008-5472.22390394
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Supplementary Table 1 from Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c806462e0c9b3e835df626b2f052e2
https://doi.org/10.1158/0008-5472.22390391.v1
https://doi.org/10.1158/0008-5472.22390391.v1
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Current drug therapy for metastatic renal cell cancer (RCC) results in temporary disease control but not cure, necessitating continued investigation into alternative mechanistic approaches. Drugs that inhibit chromatin-modifying enzymes involved in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00607ca700aa9d9c7bf3610bf0a0394f
https://doi.org/10.1158/0008-5472.c.6502931.v1
https://doi.org/10.1158/0008-5472.c.6502931.v1
Autor:
Yogen Saunthararajah, Brian Rini, Daniel Lindner, Pierre Triozzi, Kwok Peng Ng, Oscar Alcazar, Zhenbo Hu, Soledad Negrotto
Supplementary Figure 2 from Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982f445fd6b18fdc9f70108720f8aaa9
https://doi.org/10.1158/0008-5472.22390400.v1
https://doi.org/10.1158/0008-5472.22390400.v1
Autor:
Sudipta Biswas, Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt Schalper, Hua Zhang, Daniel Lindner, Anish Thomas, David MacPherson, Brian Gastman, David Schrump, Kwok-Kin Wong, Vamsi Velcheti, Yogen Saunthararajah
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f4780a67943785ef366009cb17065d
https://doi.org/10.2139/ssrn.4376283
https://doi.org/10.2139/ssrn.4376283
Autor:
Sunisa Kongkiatkamon, Xiaorong Gu, Kwok Peng Ng, Simona Pagliuca, Vera Adema, Wencke Walter, Yasunobu Nagata, Cassandra M Kerr, Manja Meggendorfer, Hassan Awada, Stephan Hutter, Carmelo Gurnari, Claudia Haferlach, Babal K. Jha, Valeria Visconte, Torsten Haferlach, Jaroslaw P. Maciejewski, Yogenthiran Saunthararajah
Publikováno v:
Blood. 138:1148-1148
Introduction/Methods: Enzymes that modify histone H3 at lysine 27 (H3K27) to thereby regulate gene transcription (epigenetic enzymes) are recurrently inactivated by deletion and/or mutation in myelodysplastic syndromes (MDS), myeloproliferative neopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96989b05d738d0315176743064cda704
https://doi.org/10.1182/blood-2021-153618
https://doi.org/10.1182/blood-2021-153618